PRF Technologies (PRFX) Capital Expenditures (2020 - 2024)

PRF Technologies (PRFX) posted quarterly Capital Expenditures of -$5000.0 for Q2 2024, up 28.57% on a QoQ basis from -$7000.0 in Q1 2024.

PRF Technologies (PRFX) Capital Expenditures (2020 - 2024) Analysis & Trends

PRF Technologies (PRFX) has reported Capital Expenditures for 5 consecutive years, with -$5000.0 the latest figure, recorded in Q2 2024.

  • Quarterly Capital Expenditures changed N/A year-over-year to -$5000.0 in Q2 2024, while the trailing twelve-month figure through Jun 2024 was -$3000.0 (changed N/A YoY) and the FY2025 annual result came in at $2000.0, down 84.62% from the prior year.
  • Capital Expenditures climbed to -$5000.0 in Q2 2024 per PRFX's latest filing, from -$7000.0 in the prior quarter.
  • Over the last five years, Capital Expenditures for PRFX reached as high as $240000.0 in Q1 2022 and fell as low as -$243000.0 in Q2 2022.
  • A 5-year average of -$1272.7 and a median of -$6000.0 in 2021 frame the typical range for Capital Expenditures.
  • The largest YoY upside for Capital Expenditures was 1946.15% in 2022 against a maximum downside of 8000.0% in 2022.
  • Year by year, Capital Expenditures stood at -$58000.0 in 2020, then soared by 224.14% to $72000.0 in 2021, then slumped by 437.5% to -$243000.0 in 2022, then soared by 107.0% to $17000.0 in 2023, then sank by 129.41% to -$5000.0 in 2024.
  • According to Business Quant data, Capital Expenditures over the past three periods registered -$5000.0, -$7000.0, and $17000.0 for Q2 2024, Q1 2024, and Q4 2023 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 168.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 110.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 1.95 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 99.60 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 39.90 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 1.40 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 51.00 Mn
10 PRF Technologies 745,168.93 451,168.93 - -

Historic Data

Download Data
DateValue
Jun 30, 2024 -5,000.00
Jun 30, 2024 -5,000.00
Mar 31, 2024 -7,000.00
Mar 31, 2024 -7,000.00
Dec 31, 2023 17,000.00
Dec 31, 2023 17,000.00
Sep 30, 2023 -8,000.00
Sep 30, 2023 -8,000.00
Jun 30, 2022 -243,000.00
Jun 30, 2022 -243,000.00
Mar 31, 2022 240,000.00
Mar 31, 2022 240,000.00
Dec 31, 2021 72,000.00
Dec 31, 2021 72,000.00
Sep 30, 2021 -6,000.00
Sep 30, 2021 -6,000.00
Jun 30, 2021 -3,000.00
Jun 30, 2021 -3,000.00
Mar 31, 2021 -13,000.00
Mar 31, 2021 -13,000.00